Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)
INR 1806.5
(0.3%)
INR 1806.5
(0.3%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 258.48 Billion INR | -20.75% |
| 2022 | 326.16 Billion INR | 22.07% |
| 2021 | 267.18 Billion INR | 14.9% |
| 2020 | 232.53 Billion INR | 6.41% |
| 2019 | 218.53 Billion INR | 12.37% |
| 2018 | 194.47 Billion INR | 12.81% |
| 2017 | 172.39 Billion INR | -16.19% |
| 2016 | 205.69 Billion INR | 1.62% |
| 2015 | 202.42 Billion INR | 3.75% |
| 2014 | 195.1 Billion INR | 54.52% |
| 2013 | 126.26 Billion INR | 44.96% |
| 2012 | 87.1 Billion INR | 44.71% |
| 2011 | 60.19 Billion INR | 41.28% |
| 2010 | 42.6 Billion INR | 51.83% |
| 2009 | 28.06 Billion INR | -17.87% |
| 2008 | 34.16 Billion INR | 29.7% |
| 2007 | 26.34 Billion INR | 69.38% |
| 2006 | 15.55 Billion INR | 35.29% |
| 2005 | 11.49 Billion INR | 31.4% |
| 2004 | 8.74 Billion INR | 17.27% |
| 2003 | 7.46 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 68.67 Billion INR | 3.23% |
| 2024 Q2 | 105.7 Billion INR | 9.12% |
| 2023 Q4 | 66.52 Billion INR | -29.38% |
| 2023 Q3 | 94.19 Billion INR | 2.21% |
| 2023 Q2 | 92.16 Billion INR | 2.09% |
| 2023 Q1 | 90.26 Billion INR | 6.51% |
| 2023 FY | 258.48 Billion INR | -20.75% |
| 2022 FY | 326.16 Billion INR | 22.07% |
| 2022 Q4 | 84.75 Billion INR | 2.16% |
| 2022 Q2 | 81.01 Billion INR | 4.61% |
| 2022 Q1 | 77.43 Billion INR | 41.04% |
| 2022 Q3 | 82.96 Billion INR | 2.41% |
| 2021 Q4 | 54.9 Billion INR | -23.46% |
| 2021 FY | 267.18 Billion INR | 14.9% |
| 2021 Q1 | 70.2 Billion INR | 40.53% |
| 2021 Q2 | 70.34 Billion INR | 0.21% |
| 2021 Q3 | 71.73 Billion INR | 1.97% |
| 2020 FY | 232.53 Billion INR | 6.41% |
| 2020 Q4 | 49.95 Billion INR | -22.54% |
| 2020 Q3 | 64.48 Billion INR | 2.15% |
| 2020 Q2 | 63.12 Billion INR | 14.82% |
| 2020 Q1 | 54.97 Billion INR | 21.3% |
| 2019 Q1 | 58.01 Billion INR | 51.25% |
| 2019 Q2 | 56.81 Billion INR | -2.07% |
| 2019 FY | 218.53 Billion INR | 12.37% |
| 2019 Q3 | 58.38 Billion INR | 2.77% |
| 2019 Q4 | 45.32 Billion INR | -22.37% |
| 2018 Q2 | 50.88 Billion INR | 1.13% |
| 2018 FY | 194.47 Billion INR | 12.81% |
| 2018 Q4 | 38.35 Billion INR | -30.15% |
| 2018 Q3 | 54.91 Billion INR | 7.9% |
| 2018 Q1 | 50.32 Billion INR | 1.84% |
| 2017 Q1 | 44.89 Billion INR | -3.04% |
| 2017 FY | 172.39 Billion INR | -16.19% |
| 2017 Q4 | 49.4 Billion INR | 9.84% |
| 2017 Q3 | 44.98 Billion INR | -4.54% |
| 2017 Q2 | 47.12 Billion INR | 4.97% |
| 2016 Q1 | 61.59 Billion INR | 3.32% |
| 2016 FY | 205.69 Billion INR | 1.62% |
| 2016 Q4 | 46.29 Billion INR | -14.81% |
| 2016 Q3 | 54.34 Billion INR | -8.26% |
| 2016 Q2 | 59.24 Billion INR | -3.82% |
| 2015 Q2 | 52.45 Billion INR | 9.16% |
| 2015 Q3 | 52.91 Billion INR | 0.88% |
| 2015 Q1 | 48.04 Billion INR | 5.92% |
| 2015 Q4 | 59.61 Billion INR | 12.68% |
| 2015 FY | 202.42 Billion INR | 3.75% |
| 2014 Q4 | 45.36 Billion INR | 24.67% |
| 2014 Q2 | 39.39 Billion INR | 24.6% |
| 2014 Q1 | 31.62 Billion INR | 13.99% |
| 2014 FY | 195.1 Billion INR | 54.52% |
| 2014 Q3 | 36.38 Billion INR | -7.65% |
| 2013 Q1 | 29.56 Billion INR | 41.25% |
| 2013 Q2 | 33.91 Billion INR | 14.71% |
| 2013 Q3 | 35.04 Billion INR | 3.32% |
| 2013 Q4 | 27.74 Billion INR | -20.83% |
| 2013 FY | 126.26 Billion INR | 44.96% |
| 2012 Q1 | 21.55 Billion INR | 44.39% |
| 2012 Q3 | 22.92 Billion INR | 5.72% |
| 2012 Q4 | 20.93 Billion INR | -8.7% |
| 2012 FY | 87.1 Billion INR | 44.71% |
| 2012 Q2 | 21.68 Billion INR | 0.6% |
| 2011 Q4 | 14.93 Billion INR | -15.51% |
| 2011 Q3 | 17.67 Billion INR | 15.29% |
| 2011 Q2 | 15.32 Billion INR | 24.75% |
| 2011 Q1 | 12.28 Billion INR | 0.0% |
| 2011 FY | 60.19 Billion INR | 41.28% |
| 2010 FY | 42.6 Billion INR | 51.83% |
| 2009 FY | 28.06 Billion INR | -17.87% |
| 2008 FY | 34.16 Billion INR | 29.7% |
| 2007 FY | 26.34 Billion INR | 69.38% |
| 2006 FY | 15.55 Billion INR | 35.29% |
| 2005 FY | 11.49 Billion INR | 31.4% |
| 2004 FY | 8.74 Billion INR | 17.27% |
| 2003 FY | 7.46 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Sigachi Industries Limited | 2 Billion INR | -12809.549% |
| Ind-Swift Limited | 2.17 Billion INR | -11797.906% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -17462.484% |
| Sakar Healthcare Limited | 699.58 Million INR | -36848.434% |
| Aurobindo Pharma Limited | 109.54 Billion INR | -135.966% |
| Innova Captab Limited | 3.46 Billion INR | -7361.111% |
| Divi's Laboratories Limited | 32.44 Billion INR | -696.812% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -4053.916% |
| Morepen Laboratories Limited | 6.16 Billion INR | -4095.324% |
| Mankind Pharma Limited | 42.19 Billion INR | -512.569% |
| Sequent Scientific Limited | 2.97 Billion INR | -8577.715% |
| Wanbury Limited | 1.73 Billion INR | -14835.819% |
| Laurus Labs Limited | 15.44 Billion INR | -1573.187% |
| Nectar Lifesciences Limited | 4.82 Billion INR | -5259.116% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -1979.031% |
| Alembic Limited | 1 Billion INR | -25745.804% |
| Hikal Limited | 5.95 Billion INR | -4238.464% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | -865.194% |
| Neuland Laboratories Limited | 8.24 Billion INR | -3033.981% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | -1593.998% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | -272.777% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | -5377.436% |
| Themis Medicare Limited | 2.42 Billion INR | -10581.196% |
| RPG Life Sciences Limited | 2.48 Billion INR | -10310.217% |
| Zydus Lifesciences Limited | 125.21 Billion INR | -106.44% |
| Lupin Limited | 125.09 Billion INR | -106.631% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -12243.894% |
| Wockhardt Limited | 7.72 Billion INR | -3248.26% |
| Vaishali Pharma Limited | 90.32 Million INR | -286079.268% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -4332.689% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -39509.203% |
| Jubilant Pharmova Limited | 19.64 Billion INR | -1215.918% |
| FDC Limited | 6.58 Billion INR | -3824.65% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | -57.992% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -41559.191% |
| Eris Lifesciences Limited | 10.42 Billion INR | -2379.053% |
| Venus Remedies Limited | 2.18 Billion INR | -11743.099% |
| ZIM Laboratories Limited | 1.26 Billion INR | -20288.314% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -6894.73% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -48750.522% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | -2707.644% |
| Shilpa Medicare Limited | 3.56 Billion INR | -7156.967% |
| Albert David Limited | 1.4 Billion INR | -18257.225% |
| Ajanta Pharma Limited | 21.06 Billion INR | -1127.144% |
| Hester Biosciences Limited | 1.27 Billion INR | -20194.877% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -6168.943% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 15709.982% |
| Gufic Biosciences Limited | 4.07 Billion INR | -6245.18% |
| Windlas Biotech Limited | 1.33 Billion INR | -19207.268% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -4370.988% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -228589.717% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -37297.037% |
| Granules India Limited | 16.79 Billion INR | -1438.671% |
| Aarti Drugs Limited | 8.31 Billion INR | -3008.219% |
| Bal Pharma Limited | 770.19 Million INR | -33461.072% |
| Alkem Laboratories Limited | 52.29 Billion INR | -394.266% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -13599.208% |
| Medicamen Biotech Limited | 495.49 Million INR | -52067.166% |
| Unichem Laboratories Limited | 4.86 Billion INR | -5213.245% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -57067.751% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -2060367.916% |
| Valiant Laboratories Limited | 138.02 Million INR | -187169.125% |
| Orchid Pharma Limited | 2.32 Billion INR | -11040.17% |
| Medico Remedies Limited | 262.14 Million INR | -98504.469% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | -6153.862% |
| Ipca Laboratories Limited | 48.58 Billion INR | -432.038% |
| Brooks Laboratories Limited | 65.62 Million INR | -393812.984% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -46099.162% |
| Piramal Enterprises Limited | 8.04 Billion INR | -3113.677% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | -452.824% |
| NATCO Pharma Limited | 25.73 Billion INR | -904.374% |
| Suven Life Sciences Limited | -200.79 Million INR | 128829.862% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 237794.557% |
| Strides Pharma Science Limited | 14.38 Billion INR | -1696.523% |
| Indoco Remedies Limited | 8.04 Billion INR | -3113.797% |
| Alpa Laboratories Limited | 188.89 Million INR | -136740.943% |
| Lasa Supergenerics Limited | 121.02 Million INR | -213471.596% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -65997.718% |